Humira combined with Naprosyn

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Mass Required Intervention 1/18/2006 61 Female 200 lb 6/16/2006 Physician United States
Primary
Secondary
Concomitant
Basal Cell Carcinoma Other Serious 7/1/2005 Male 7/10/2006 Physician United States
Primary
Concomitant
Crohn's Disease Other Serious 10/1/2006 Male 231 lb 3/20/2007 Physician United States
Primary
Concomitant
Pancreatitis Hospitalization 4/23/2007 54 Male 10/9/2007 Physician United States
Primary
Concomitant
Weight Decreased 7/1/2007 Female 106 lb 12/14/2007 United States
Primary
Concomitant
Myocardial Infarction Life Threatening 12/12/2007 Male 1/28/2008 Other Health Professional United States
Primary
Concomitant
Drug Ineffective 10/4/2006 Female 124 lb 3/14/2008 Consumer United States
Primary
Concomitant
Bladder Cancer Other Serious 4/1/2008 Male 180 lb 6/5/2008 United States
Primary
Concomitant
Accidental Exposure 5/6/2008 Female 170 lb 6/13/2008 Other Health Professional United States
Primary
Concomitant
Myalgia Other Serious 6/1/2008 65 Female 140 lb 7/17/2008 Consumer United States
Primary
Concomitant
White Blood Cell Count Abnormal Other Serious 3/11/2008 Female 178 lb 8/19/2008 Consumer United States
Primary
Concomitant
Rash Papular 5/28/2008 Female 195 lb 9/12/2008 Physician United States
Primary
Concomitant
Skin Wrinkling 4/23/2008 Female 135 lb 9/12/2008 United States
Primary
Concomitant
Pain 5/18/2008 Female 280 lb 9/12/2008 United States
Primary
Concomitant
Injection Site Pain 7/3/2008 Female 9/12/2008 United States
Primary
Concomitant
Accidental Exposure 6/4/2008 Male 200 lb 9/12/2008 United States
Primary
Concomitant
Joint Swelling 5/28/2008 Female 180 lb 9/12/2008 Consumer United States
Primary
Concomitant
Herpes Zoster 7/24/2008 Male 180 lb 9/12/2008 United States
Primary
Concomitant
Injection Site Irritation 7/14/2008 Female 101 lb 9/12/2008 Consumer United States
Primary
Concomitant
Dry Skin 5/1/2008 Male 220 lb 9/12/2008 United States
Primary
Concomitant
Malaise 3/1/2008 Female 9/13/2008 United States
Primary
Concomitant
Condition Aggravated Other Serious Female 121 lb 9/22/2008 Canada
Primary
Concomitant
Sinusitis Other Serious 7/12/2008 Female 156 lb 10/1/2008 Canada
Primary
Concomitant
Visual Acuity Reduced Other Serious 2/1/2007 Female 10/7/2008 Canada
Primary
Concomitant
Oedema Peripheral Other Serious 12/1/2007 Female 230 lb 10/15/2008 Canada
Primary
Concomitant
Sinusitis Other Serious 7/12/2008 Female 156 lb 11/7/2008 Canada
Primary
Concomitant
Vaginal Haemorrhage Other Serious Female 157 lb 11/12/2008 Canada
Primary
Concomitant
Vaginal Haemorrhage Other Serious Female 157 lb 11/26/2008 Canada
Primary
Concomitant
Asthenia 11/24/2008 Female 139 lb 12/10/2008 Physician United States
Primary
Concomitant
Hypertension 9/15/2008 Female 12/12/2008 Consumer United States
Primary
Concomitant
Pain In Extremity 9/1/2008 Female 12/12/2008 United States
Primary
Concomitant
Fatigue 8/1/2007 Male 12/12/2008 Consumer United States
Primary
Secondary
Concomitant
Fall Other Serious 1/13/2009 Female 170 lb 1/19/2009 United States
Primary
Concomitant
Nausea Other Serious 1/8/2009 Female 170 lb 1/21/2009 Canada
Primary
Concomitant
Pneumonia Life Threatening 6/23/2008 Female 130 lb 2/26/2009 United States
Primary
Concomitant
Pneumonia Life Threatening 6/23/2008 Female 130 lb 3/10/2009 United States
Primary
Concomitant
Large Intestine Perforation Hospitalization 2/7/2006 Male 209 lb 3/13/2009 Netherlands
Primary
Concomitant
Injection Site Pain 1/1/2008 Female 56 lb 3/14/2009 United States
Primary
Concomitant
Therapy Regimen Changed 9/1/2008 Female 150 lb 3/14/2009 Consumer United States
Primary
Concomitant
Sinusitis 11/24/2008 Female 140 lb 3/14/2009 United States
Primary
Concomitant
Sneezing 12/1/2008 Female 162 lb 3/14/2009 Other Health Professional United States
Primary
Concomitant
Pain In Extremity 9/1/2008 Female 200 lb 3/14/2009 Consumer United States
Primary
Concomitant
Injection Site Pain 12/18/2008 Female 3/14/2009 Consumer United States
Primary
Concomitant
Walking Aid User 1/1/2009 Female 3/14/2009 United States
Primary
Concomitant
Urticaria 2/21/2009 Male 3/14/2009 Physician United States
Primary
Concomitant
Injection Site Pruritus 1/1/2009 Male 240 lb 3/14/2009 Consumer United States
Primary
Concomitant
Vomiting Other Serious 1/1/2008 Female 178 lb 3/20/2009 Consumer United States
Primary
Concomitant
Secretion Discharge Other Serious 3/25/2009 Male 310 lb 4/16/2009 Canada
Primary
Concomitant
Wound Drainage Other Serious 12/3/2008 Female 160 lb 4/24/2009 Canada
Primary
Concomitant
Secretion Discharge Other Serious 3/25/2009 Male 310 lb 5/5/2009 Canada
Primary
Concomitant
Ventriculoperitoneal Shunt Malfunction Other Serious 1/1/2007 Female 140 lb 5/8/2009 Consumer United States
Primary
Concomitant
Ventriculoperitoneal Shunt Malfunction Other Serious 1/1/2007 Female 140 lb 5/8/2009 Other Health Professional United States
Primary
Concomitant
Ventriculoperitoneal Shunt Malfunction Other Serious 1/1/2007 Female 140 lb 5/8/2009 Other Health Professional United States
Primary
Concomitant
Oedema Peripheral Other Serious 5/12/2009 Female 160 lb 5/21/2009 Canada
Primary
Concomitant
Oedema Peripheral Other Serious 5/12/2009 Female 160 lb 5/22/2009 Canada
Primary
Concomitant
Dyspnoea Other Serious Male 150 lb 5/28/2009 Canada
Primary
Concomitant
Ulcer Haemorrhage Other Serious 5/20/2009 Male 208 lb 6/5/2009 Canada
Primary
Secondary
Concomitant
Accidental Exposure 9/7/2008 Female 140 lb 6/11/2009 United States
Primary
Concomitant
Injection Site Irritation 10/1/2008 Male 6/11/2009 Other Health Professional United States
Primary
Concomitant
Eye Infection Staphylococcal 3/7/2009 Female 188 lb 6/11/2009 Consumer United States
Primary
Concomitant
Pyrexia Female 52 lb 6/11/2009 Consumer United States
Primary
Concomitant
Palpitations 1/1/2004 Female 170 lb 6/11/2009 Physician United States
Primary
Concomitant
Injection Site Haematoma Hospitalization 1/1/2008 Male 200 lb 6/12/2009 Consumer United States
Primary
Concomitant
Psoriasis 12/1/2008 Male 135 lb 6/12/2009 United States
Primary
Concomitant
Injection Site Pain 4/4/2009 Female 130 lb 6/12/2009 United States
Primary
Concomitant
Paraesthesia 4/29/2009 Male 140 lb 6/12/2009 United States
Primary
Concomitant
Drug Dose Omission 5/8/2009 Male 216 lb 6/12/2009 Consumer United States
Primary
Concomitant
Injection Site Pain 6/1/2008 Female 109 lb 6/12/2009 Consumer United States
Primary
Concomitant
Wrong Technique In Drug Usage Process 5/28/2009 Female 145 lb 6/12/2009 Physician United States
Primary
Concomitant
Upper Gastrointestinal Haemorrhage Other Serious 5/20/2009 Male 208 lb 6/16/2009 Canada
Primary
Secondary
Concomitant
Pancreatic Neoplasm Other Serious 4/1/2009 Male 159 lb 6/17/2009 Belgium
Primary
Concomitant
Diarrhoea Hospitalization Female 7/14/2009 Belgium
Primary
Concomitant
Vaginal Haemorrhage Other Serious Female 157 lb 7/16/2009 Canada
Primary
Concomitant
Urinary Tract Infection Other Serious 4/1/2009 Female 240 lb 7/17/2009 United Kingdom
Primary
Concomitant
Wound Drainage Other Serious 5/12/2009 Female 160 lb 8/10/2009 Canada
Primary
Concomitant
Upper Limb Fracture Other Serious Female 8/24/2009 Canada
Primary
Concomitant
Injection Site Extravasation 10/10/2006 Female 180 lb 9/11/2009 Consumer United States
Primary
Concomitant
Injection Site Irritation 11/3/2006 Female 130 lb 9/11/2009 Consumer United States
Primary
Concomitant
Injection Site Nodule 10/1/2006 Female 165 lb 9/11/2009 Consumer United States
Primary
Concomitant
Accidental Needle Stick 5/6/2008 Female 170 lb 9/12/2009 Other Health Professional United States
Primary
Concomitant
Wrong Technique In Drug Usage Process 9/7/2008 Female 140 lb 9/12/2009 United States
Primary
Concomitant
Incorrect Dose Administered 6/4/2008 Male 200 lb 9/12/2009 United States
Primary
Concomitant
Joint Swelling 5/28/2008 Female 180 lb 9/12/2009 Consumer United States
Primary
Concomitant
Peritoneal Adhesions Other Serious Female 170 lb 9/14/2009 Canada
Primary
Concomitant
Wound Drainage Other Serious 5/12/2009 Female 160 lb 9/18/2009 Canada
Primary
Concomitant
Tooth Abscess 8/17/2009 Female 123 lb 9/18/2009 United States
Primary
Concomitant
Injection Site Laceration 5/29/2009 Female 105 lb 9/18/2009 Consumer United States
Primary
Concomitant
Drug Dose Omission Female 9/18/2009 Consumer United States
Primary
Concomitant
Injection Site Urticaria 4/1/2009 Male 125 lb 9/18/2009 United States
Primary
Concomitant
Psoriasis 3/9/2009 Male 188 lb 9/18/2009 United States
Primary
Concomitant
Pain 5/11/2009 Female 120 lb 9/18/2009 United States
Primary
Concomitant
Injection Site Swelling 5/27/2009 Female 255 lb 9/19/2009 United States
Primary
Concomitant
Drug Dose Omission 6/25/2009 Female 135 lb 9/19/2009 Consumer United States
Primary
Concomitant
Weight Increased 2/1/2009 Male 190 lb 9/19/2009 Consumer United States
Primary
Concomitant
Arthritis Female 9/19/2009 United States
Primary
Concomitant
Injection Site Pain 1/1/2009 Female 160 lb 9/19/2009 United States
Primary
Concomitant
Injection Site Pain 8/4/2009 Female 160 lb 9/19/2009 Consumer United States
Primary
Concomitant
Wrong Technique In Drug Usage Process 8/7/2009 Female 175 lb 9/19/2009 Consumer United States
Primary
Concomitant
Drug Dose Omission 8/13/2009 Female 240 lb 9/19/2009 Consumer United States
Primary
Concomitant
Injection Site Pain 7/1/2009 Male 195 lb 9/19/2009 Consumer United States
Primary
Concomitant
Wound Drainage Other Serious 5/12/2009 Female 160 lb 9/22/2009 Canada
Primary
Concomitant
Diarrhoea Hospitalization Female 9/28/2009 Belgium
Primary
Concomitant
Pustular Psoriasis Other Serious 8/1/2009 Female 165 lb 9/28/2009 Physician France
Primary
Concomitant
Wound Other Serious 8/1/2008 Female 139 lb 10/8/2009 Brazil
Primary
Concomitant
Pyrexia Hospitalization 7/31/2009 Male 150 lb 10/12/2009 Canada
Primary
Concomitant
Upper Limb Fracture Other Serious Female 130 lb 10/15/2009 Canada
Primary
Concomitant
Leishmaniasis Hospitalization 8/20/2005 Female 99 lb 10/28/2009 Italy
Primary
Concomitant
Septic Shock Other Serious 10/1/2009 Female 130 lb 11/4/2009 Canada
Primary
Concomitant
Leishmaniasis Hospitalization 8/20/2005 Female 99 lb 11/4/2009 Italy
Primary
Concomitant
Pulmonary Embolism Hospitalization 2/26/2009 Female 11/6/2009 Physician Australia
Primary
Concomitant
Weight Decreased Hospitalization 1/1/2009 Female 150 lb 11/18/2009 Canada
Primary
Secondary
Concomitant
Wound Other Serious 8/1/2008 Female 139 lb 12/4/2009 Brazil
Primary
Concomitant
Pain Other Serious 11/18/2009 Female 140 lb 12/14/2009 Canada
Primary
Concomitant
Paraesthesia Other Serious 11/18/2009 Female 140 lb 12/29/2009 Canada
Primary
Concomitant
Thermal Burn Other Serious 1/1/2008 Female 130 lb 1/6/2010 United States
Primary
Concomitant
Thermal Burn Other Serious 1/1/2008 Female 130 lb 1/15/2010 United States
Primary
Concomitant
Thermal Burn Other Serious 1/1/2008 Female 1/25/2010 Consumer United States
Primary
Secondary
Concomitant
Tooth Abscess 8/17/2009 Female 123 lb 1/29/2010 United States
Primary
Concomitant
Poor Quality Drug Administered 6/1/2009 Female 128 lb 1/29/2010 Consumer United States
Primary
Concomitant
Injection Site Pain 9/16/2009 Male 170 lb 1/29/2010 Consumer United States
Primary
Concomitant
Rectal Abscess Other Serious 12/1/2008 Male 1/29/2010 United States
Primary
Concomitant
Urinary Tract Infection 6/1/2009 Female 180 lb 1/29/2010 United States
Primary
Concomitant
Psoriasis 9/15/2009 Female 1/30/2010 United States
Primary
Concomitant
Drug Ineffective Male 231 lb 1/30/2010 Consumer United States
Primary
Concomitant
Poor Quality Sleep 9/1/2009 Male 200 lb 1/30/2010 United States
Primary
Concomitant
Injection Site Pain 11/1/2009 Female 126 lb 1/30/2010 Consumer United States
Primary
Concomitant
Mobility Decreased Female 250 lb 1/30/2010 United States
Primary
Concomitant
Tooth Infection 12/29/2009 Male 210 lb 1/30/2010 United States
Primary
Concomitant
Macular Degeneration Other Serious 1/1/2009 Female 215 lb 2/5/2010 United States
Primary
Concomitant
Vaginal Prolapse Hospitalization 1/1/2009 Female 150 lb 2/8/2010 Canada
Primary
Concomitant
Vaginal Prolapse Hospitalization 1/1/2009 Female 150 lb 2/9/2010 Canada
Primary
Concomitant
Panniculitis Other Serious 60 Female 2/24/2010 Physician Spain
Primary
Concomitant
Female Genital Tract Fistula Hospitalization 1/11/2010 Female 140 lb 3/5/2010 United States
Primary
Concomitant
Palpitations Other Serious 1/1/2004 Female 170 lb 3/5/2010 Physician United States
Primary
Concomitant
Palpitations Other Serious 1/1/2007 Female 170 lb 3/9/2010 Physician United States
Primary
Concomitant
Vitamin D Decreased Other Serious 3/1/2008 Male 3/11/2010 Physician United States
Primary
Concomitant
Female Genital Tract Fistula Hospitalization 1/11/2010 Female 140 lb 3/12/2010 United States
Primary
Concomitant
Panniculitis Other Serious 60 Female 4/1/2010 Physician Spain
Primary
Concomitant
Wound Secretion Other Serious 1/1/2009 48 Female 218 lb 4/2/2010 Canada
Primary
Concomitant
Female Genital Tract Fistula Hospitalization 1/11/2010 78 Female 140 lb 4/30/2010 United States
Primary
Concomitant
Fall Hospitalization 5/29/2009 78 Female 165 lb 5/18/2010 Netherlands
Primary
Concomitant
Tachyphrenia Other Serious 2/11/2009 37 Male 5/21/2010 Canada
Primary
Concomitant
Hypertensive Crisis Hospitalization 12/12/2005 57 Female 234 lb 5/28/2010 Italy
Primary
Concomitant
Tachyphrenia Other Serious 2/11/2009 37 Male 5/28/2010 Canada
Primary
Concomitant
Renal Failure Acute Other Serious 7/14/2008 54 Female 6/18/2010 Physician Belgium
Primary
Concomitant
Pancreatic Neoplasm Other Serious 4/1/2009 52 Male 159 lb 7/8/2010 Physician Belgium
Primary
Concomitant
Unevaluable Event 9/1/2006 60 Female 147 lb 7/8/2010 Consumer United States
Primary
Secondary
Concomitant
Fall Hospitalization 5/29/2009 78 Female 165 lb 7/9/2010 Physician Netherlands
Primary
Concomitant
Osteoarthritis Other Serious 1/1/2009 66 Female 7/23/2010 Consumer United States
Primary
Concomitant
Weight Increased 1/1/2008 50 Male 160 lb 8/3/2010 Consumer United States
Primary
Concomitant

Drug Data